含锶硼硅酸盐生物玻璃的降解性能及体外生物活性

研究了含锶硼硅酸盐玻璃的体外生物活性和降解性。采用熔融法制备不同锶含量(SrO含量为0、2%、4%、6%、8%、10%、12%(摩尔分数))的硼硅酸盐生物玻璃粉末,粒径范围为150～300μm。将各组玻璃样品浸泡在0.02mol/L的K2HPO4溶液中,置于37℃恒温条件下,进行体外生物矿化反应。通过对反应样品的质量损失以及浸泡液pH值进行测定,并用XRD、FTIR以及SEM对反应过程和反应后产物进行表征。结果表明,含锶的硼硅酸盐玻璃在体外生物矿化反应中被生物降解,并转化为含锶羟基磷灰石,具有很好的生物活性和降解性;同时也观察到玻璃中引入锶元素后,在一定程度上控制玻璃的降解速度,进而控制硼的溶出速度,从一定程度上避免硼溶出速度过高可能带来的风险;ICP的结构也表明,当SrO为6%(摩尔分数),样品中硼元素溶出的速度最低。因此,用锶的含量可控制硼硅酸盐玻璃的降解速度,这种方法将在组织工程领域具有广阔的应用前景。     

硼硅酸盐生物活性玻璃在直流电场下的体外矿化性能

硼硅酸盐生物活性玻璃具有良好的生物活性和骨传导性, 但大多数生物活性玻璃表现出非线性降解和矿化行为, 矿化性能会随着时间而减缓。电场作为一种外场辅助调节的方法, 能够干预玻璃的离子交换和扩散。本研究利用直流电场干预硼硅酸盐生物活性玻璃的体外矿化, 加快降解较慢阶段中硼硅酸盐生物玻璃的生物活性。将熔融法制备的成分为18SiO₂-6Na₂O-8K₂O-8MgO-22CaO-2P₂O₅-36B₂O₃的硼硅酸盐生物活性玻璃浸泡在SBF生理模拟液中, 施加0~90 mA的电流, 研究直流电场对硼硅酸盐生物玻璃降解及体外矿化性能的影响。研究结果表明, 施加电场不仅可以提高硼硅酸盐生物活性玻璃的降解率和离子释放量, 而且有利于玻璃网络水解和表面羟基化, 加速羟基磷灰石的生成。其中失重率比对照组提高了3%~5%, 硼和钙的离子释放量分别较对照组提高了2.3~2.9倍和1.9~2.3倍。对硼硅酸盐生物活性玻璃表面结构分析得出, 暴露在电场下的样品表面生成了磷灰石层。应用直流电场可以提高生物活性玻璃的降解及体外矿化性能, 为提升骨修复效果提供了一种新思路。     

硼硅酸盐生物活性玻璃在直流电场下的体外矿化性能（英文）

硼硅酸盐生物活性玻璃具有良好的生物活性和骨传导性,但大多数生物活性玻璃表现出非线性降解和矿化行为,矿化性能会随着时间而减缓。电场作为一种外场辅助调节的方法,能够干预玻璃的离子交换和扩散。本研究利用直流电场干预硼硅酸盐生物活性玻璃的体外矿化,加快降解较慢阶段中硼硅酸盐生物玻璃的生物活性。将熔融法制备的成分为18SiO₂-6Na₂O-8K₂O-8MgO-22CaO-2P₂O₅-36B₂O₃的硼硅酸盐生物活性玻璃浸泡在SBF生理模拟液中,施加0～90 m A的电流,研究直流电场对硼硅酸盐生物玻璃降解及体外矿化性能的影响。研究结果表明,施加电场不仅可以提高硼硅酸盐生物活性玻璃的降解率和离子释放量,而且有利于玻璃网络水解和表面羟基化,加速羟基磷灰石的生成。其中失重率比对照组提高了3%～5%,硼和钙的离子释放量分别较对照组提高了2.3～2.9倍和1.9～2.3倍。对硼硅酸盐生物活性玻璃表面结构分析得出,暴露在电场下的样品表面生成了磷灰石层。应用直...     

光热核壳TiN@硼硅酸盐生物玻璃纳米颗粒的降解和矿化性能（英文）

硼硅酸盐生物玻璃以其稳定的结构和优异的生物活性而受到广泛关注,但生物玻璃在矿化过程中活性呈现初期快而中后期慢的趋势,造成后期的活性降低。光热可加速生物玻璃降解,本研究制备了以氮化钛为核、生物玻璃(40SiO₂-20B₂O₃-36CaO-4P₂O₅)为壳的复合生物玻璃,利用光热场干预生物玻璃的矿化过程。结果表明,生物玻璃具有显著的光热效应,光热能力随氮化钛掺杂量和激光功率密度的增加而提高；在体外浸泡中,近红外光辐照促进了生物玻璃的降解,浸泡7 d后模拟体液中钙、硼的含量分别增加12%～16%和8%～11%,加速了羟基磷灰石的生成；细胞增殖活性实验表明样品有良好的生物安全性。因此,光热场可促进生物玻璃降解和矿化,对周围细胞影响小,有望在保障初期生物安全的同时发挥调节作用。     

一种新型的骨组织工程用支架材料的制备与性能表征

以硼硅酸盐玻璃粉为原料,采用有机泡沫浸渍工艺,制备了高孔隙率的网眼多孔支架.应用XRD、SEM及ICP-AES等对硼酸盐生物玻璃粉末在生理模拟液中的降解性能、生物活性等进行了测试分析.结果表明,硼硅酸盐生物玻璃的降解性和生物活性与材料的组成配比有关,因此,可以通过调整玻璃的组成有效控制材料的降解性和表面形成的羟基磷灰石晶体的形态.硼硅酸盐生物活性玻璃作为硬组织工程支架材料的研究具有重要的意义和广泛的应用前景.     

含Zn、Mg生物玻璃的制备及性能研究

采用溶胶-凝胶法,在58S生物玻璃的基础上,分别用0.5wt％的氧化镁和氧化锌取代氧化钙制备了含镁和含锌的生物玻璃.压制的试样分别在600、700和800℃煅烧以做强度测试,并分析了600和800℃煅烧后的物相组成.结果表明,三种试样煅烧至800℃仍为玻璃态,而镁锌的掺入大幅度提高了生物玻璃的强度,这主要是因为Mg-O和Zn-O具有比Ca-O高的键能.模拟体液浸泡试验表明,镁和锌降低了羟基磷灰石的早期成核速度,但并不影响其后期的生长.浸泡三天后所有样品表面都被羟基磷灰石覆盖,表明了样品具有良好的生物活性.     

溶胶-凝胶生物活性玻璃超细粉体的制备与生物矿化性能研究

通过溶胶-凝胶和湿法研磨工艺制备了粒径分布在1μm以下的生物活性玻璃超细粉体. 采用XRD、FTIR、SEM测试方法对研磨前后粉体在模拟生理溶液(SBF)中的生物矿化性能进行了对比分析与表征, 结果表明: 在SBF中两种粉体表面都生成了碳酸羟基磷灰石(HCA), 并且经湿法研磨后的溶胶-凝胶生物活性玻璃超细粉体的生物矿化速度显著提高. 通过对不同浸泡时间SBF溶液的pH值测定可知, 在同样反应时间情况下, 超细粉体浸泡液的pH值低于研磨前颗粒. 浸泡液的ICP测试也表明研磨前后玻璃样品的离子溶出规律有所不同.     

硅酸盐生物活性陶瓷研究进展

生物陶瓷经历了由惰性生物陶瓷如氧化铝和氧化锆陶瓷到可降解生物陶瓷如磷酸三钙陶瓷及具有生物活性的生物陶瓷如羟基磷灰石陶瓷的发展过程。近年来,随着再生医学研究和组织工程技术的发展,对生物材料的性能有了更高的要求,有学者提出了第三代生物材料的概念,认为新一代生物材料应该既具有生物活性,又可降解。研究发现,一些含硅的生物玻璃兼具有这两种特性,其生物活性体现在可以在模拟体液或体内环境中诱导形成类骨磷灰石,这种类骨磷灰石可以与骨组织形成键合。此外,研究显示这类生物玻璃材料具有促进细胞增殖和成骨基因表达的作用。但是,生物活性玻璃存在不易再加工成型,进一步热处理后生物活性和降解性会发生变化等问题。在生物玻璃研究的基础上,研究了一系列钙-硅体系的硅酸盐陶瓷,证实了这类生物陶瓷具有良好的生物活性和降解性,其生物活性和降解性与其化学组成有密切的关系,细胞实验显示这类硅酸盐陶瓷也具有促进细胞增殖分化和骨组织再生的作用,有望成为新一代骨修复材料。     

介孔硼硅酸盐玻璃微球药物载体的制备及其性能表征

介孔二氧化硅微粒具有化学稳定性好、比表面积大和表面易修饰等特点, 作为药物载体具有良好的应用前景, 但其缺乏生物活性且生物降解缓慢等在一定程度上限制了它的应用领域。为克服这些缺陷, 寻找合适的药物载体已成为重要研究方向。与纯二氧化硅相比, 硼硅酸盐玻璃具有良好的生物活性和更高的降解速率。基于此, 本研究尝试合成介孔硼硅酸盐玻璃微球(MBGMs), 并表征了其在负载和释放抗肿瘤药物盐酸阿霉素(DOX)过程中的载体特性和材料降解引发的各种功能性离子的释放行为。结果表明BMGMs具有约25 mg/g的DOX负载量,引入硼不仅可以调控MBGMs的化学活性和降解速率, 而且较高硼含量的MBGMs可促进酸性条件下的药物释放, 具有一定的酸性响应性。此外, MBGMs可在模拟体液中释放SiO₄^4-、BO₃^3-和Ca²⁺等有益骨组织生长的功能性离子, 并诱导生成羟基磷灰石, 具备良好的离子缓释能力和体外矿化活性。因此, MBGMs作为一种新颖的药物载体材料, 既可作为药物和功能离子的双重负载, 又具有良好的生物活性和降解特性, 在病理性骨缺损修复领域具有良好的应用前景。     

FeO-Fe2O3-CaO-SiO2体系铁磁微晶玻璃的磁性及生物活性

具有生物活性和磁性的微晶玻璃材料被认为是温热疗法治疗癌症的有效热种子材料.本文制备了添加少量B2O3和P2O5后的FeO-Fe2O3-CaO-SiO2体系铁磁微晶玻璃,并进行了微观结构分析、XRD分析、磁性检测以及生理模拟液的浸泡实验.实验结果表明,制备的微晶玻璃材料同时具备磁性和生物活性这两种重要性能.不经过核化处理在1000℃晶化2h能够获得较理想的磁铁矿主晶相和硅灰石次晶相均匀致密分布的微观组织,所得微晶玻璃具有最佳的磁性能.铁含量提高能够增加微晶玻璃的磁性,然而会抑制微晶玻璃表面羟基磷灰石的形成,从而降低其生物活性.     

Alkali oxide containing mesoporous bioactive glasses: Synthesis,characterization and in vitro bioactivity

We report, for the first time, the synthesis of sodium oxide containing mesoporous bioactive quaternary glasses and compared with two different mesoporous ternary silicate systems by modified sol–gel process. With the aid of three different glass systems, a systematic analysis has been made on phosphorous-bearing (P-bearing) and phosphorous-free (P-free) mesoporous bioactive glasses to investigate the role of phosphorus on in vitro bioactivity of various silicate glasses with constant alkali oxide content. The combined use of multiple analytical techniques XRD, FTIR, SEM, nitrogen adsorption/desorption analysis before and after soaking in the SBF solution allowed us to establish strong correlation between composition, pore structure and bioactivity. We find that the P-bearing mesoporous glasses show the rapid hydroxycarbonate apatite (HCA) crystallization than P-free mesoporous glasses independent of calcium content. The present study reveals that the presence of phosphorous jointly with calcium in the bioactive glass system significantly enhances the rate of apatite formation as well as crystallization of apatite phase. Additionally, we find that a glass with sodium orthophosphate rich phase enhances the solubility when immersed in SBF and further accelerate the kinetics of apatite formation. The influences of the chemical composition and their superior textural properties on bioactivity are explained in terms of the unique structure of mesoporous bioactive glasses.     

Physico-chemical and in vitro biological evaluation of strontium/calcium silicophosphate glass

Strontium is known to reduce bone resorption and stimulate bone formation. Incorporation of strontium into calcium phosphate bioceramics has been widely reported. In this work, calcium and calcium/strontium silicophosphate glasses were synthesized from the sol–gel process and their rheological, thermal, and in vitro biological properties were studied and compared to each other. The results showed that the gel viscosity and thus the rate of gel formation increased by using strontium in glass composition and by increasing aging temperature. In strontium-containing glass, the crystallization temperature increased and the type of the crystallized phase was different to that of strontium-free glass. Both glasses favored precipitation of calcium phosphate layer when they were soaked in simulated body fluid; however strontium seemed to retard the rate of precipitation slightly. The in vitro biodegradation rate of the strontium/calcium silicophosphate glass was higher than that of strontium-free one. The cell culture experiments carried out using rat calvaria osteoblasts showed that the incorporation of strontium into the glass composition stimulated proliferation of the cells and enhanced their alkaline phosphatase activity, depending on cell culture period.     

Influence of SrO substitution for CaO on the properties of bioactive glass S53P4

Commercial melt-quenched bioactive glasses consist of the oxides of silicon, phosphorus, calcium and sodium. Doping of the glasses with oxides of some other elements is known to affect their capability to support hydroxyapatite formation and thus bone tissue healing but also to modify their high temperature processing parameters. In the present study, the influence of gradual substitution of SrO for CaO on the properties of the bioactive glass S53P4 was studied. Thermal analysis and hot stage microscopy were utilized to measure the thermal properties of the glasses. The in vitro bioactivity and solubility was measured by immersing the glasses in simulated body fluid for 6 h to 1 week. The formation of silica rich and hydroxyapatite layers was assessed from FTIR spectra analysis and SEM images of the glass surface. Increasing substitution of SrO for CaO decreased all characteristic temperatures and led to a slightly stronger glass network. The initial glass dissolution rate increased with SrO content. Hydroxyapatite layer was formed on all glasses but on the SrO containing glasses the layer was thinner and contained also strontium. The results suggest that substituting SrO for CaO in S53P4 glass retards the bioactivity. However, substitution greater than 10 mol% allow for precipitation of a strontium substituted hydroxyapatite layer.     

Bioactivity and cytotoxicity of glass and glass–ceramics based on the 3CaO·P2O5–SiO2–MgO system

The mechanical strength of bioactive glasses can be improved by controlled crystallization, turning its use as bulk bone implants viable. However, crystallization may affect the bioactivity of the material. The aim of this study was to develop glass–ceramics of the nominal composition (wt%) 52.75(3CaO·P₂O₅)–30SiO₂–17.25MgO, with different crystallized fractions and to evaluate their in vitro cytotoxicity and bioactivity. Specimens were heat-treated at 700, 775 and 975 °C, for 4 h. The major crystalline phase identified was whitlockite, an Mg-substituted tricalcium phosphate. The evaluation of the cytotoxicity was carried out by the neutral red uptake methodology. Ionic exchanges with the simulated body fluid SBF-K9 acellular solution during the in vitro bioactivity tests highlight the differences in terms of chemical reactivity between the glass and the glass–ceramics. The effect of crystallinity on the rates of hydroxycarbonate apatite (HCA) formation was followed by Fourier transformed infrared spectroscopy. Although all glass–ceramics can be considered bioactive, the glass–ceramic heat-treated at 775 °C (V775-4) presented the most interesting result, because the onset for HCA formation is at about 24 h and after 7 days the HCA layer dominates completely the spectrum. This occurs probably due to the presence of the whitlockite phase (3(Ca,Mg)O·P₂O₅). All samples were considered not cytotoxic.     

Evaluation of the influence of albumin on the mineralization of a glass by Atomic Force Microscopy

Bioactive glasses have been used as a graft material that can stimulate the formation of a new bone. In vitro tests usually give sensible indications about the potential bioactivity of these glasses. In the present work the influence of egg albumin on the formation of a Ca-P precipitate on a glass of the system SiO₂-CaO-MgO-P₂O₅ was evaluated. The samples were immersed in simulated body fluid (SBF) that simulates the composition of human plasma, with and without albumin. After immersion in this solution for 7 and 14 days, the glass was characterized by X-Ray Diffraction (XRD) and Atomic Force Microscopy (AFM). AFM results of the samples after immersion in SBF with albumin show the development of a precipiate formed from the solution/substrate reaction. Glasses immersed in albumin-free SBF exhibit the formation of a thin layer easily detached from the substrate. XRD results indicate that the precipitate is essentially amorphous, evolving to octacalcium phosphate. As the formation of an adherent precipitate on the glass samples only occurred when the substrate was immersed in SBF with albumin, it is suggested that albumin improves the mineralization on the glasses.     

Influence of sodium oxide content on bioactive glass properties

The rate of in vivo degradation and level of bioactivity of bioactive glasses are composition dependent [1]. By altering bioactive glass composition, the rate of resorption can be controlled. The network connectivity of a glass can be used to predict various physical properties of the glass including its solubility and, hence, its bioactivity [2]. Glass solubility increases as network connectivity is reduced. Glasses in the soda-lime phosphosilicate system were studied. The initial choice of composition was based on phosphate content and low network connectivity. A systematic substitution of calcium oxide for sodium oxide on a molar basis was made in order to examine the influence of sodium oxide content on the glass properties while keeping the network connectivity constant. The glass transition temperature and the peak crystallization temperature were seen to decrease linearly with increasing sodium oxide content. Thermal expansion coefficient and glass density were also seen to be related to sodium oxide content. Preliminary in vitro biocompatibility studies revealed that the glasses of higher sodium oxide content were associated with a cytotoxic response. The measurement of media pH indicated that this cytotoxic effect was due to ion exchange reactions at the glass surface.     

骨修复用生物玻璃复合材料研究进展

生物玻璃是一类性能优良的生物材料,具有良好的生物活性和生物相容性,作为骨修复植入体可以在材料界面与人体骨组织之间形成化学键合,诱导骨的修复与再生.将生物玻璃与其它材料进行复合,可以制备出生物活性和机械性能优良的骨修复复合材料.综述了生物玻璃复合材料的研究现状,并探讨了该类材料目前存在的不足,展望了其发展趋势.     

In vitro and in vivo biological characterizations of a new poly(amino acids)/calcium sulfate composite material for bone regeneration

A new poly(amino acids)/calcium sulfate (PAA/CS) composite was synthesized by melt polycondensation from a biodegradable PAA copolymer based on 6-aminocaproic acid and the bioactive CS. Its degradability, biocompatibility, bioactivity, and osteoconductivity were evaluated in vitro and in vivo, using phosphate buffer solution soaking test, MG63 adhesion test, and bone defect model repair test, respectively. The PAA/CS composite exhibited a much lower degradation rate than the CS, as 21.6 % of weight loss after immersing in phosphate buffer solution for 5 weeks. Moreover, the pH value of local environment restored to neutrality condition after a sharp drop in the first week. The MG63 cells adhered well on the surfaces of PAA and PAA/CS plates with their filopodium and lamellipodium, and displayed great osteogenic differentiation competence. The bone defect model repair test revealed that the composite could be intimately incorporated with the surrounding bone without causing any deleterious reaction. Radiological and histological evaluation indicated the PAA/CS granules were capable of guiding new bone formation and had a much slower degradation rate than the CS. In conclusion, the PAA/CS composite is expected to be a new bone graft material for its favorable bioactivity and biocompatibility and reasonable degradability.     

Nd3+/Yb3+共掺La2O3-TiO2-ZrO2微晶玻璃的制备及上转换发光研究

利用气悬浮方法制备了Nd³⁺/Yb³⁺共掺La₂O₃-TiO₂-ZrO₂前驱体玻璃, 通过热处理获得了微晶玻璃。通过DTA对前驱体玻璃的热稳定性进行了研究。利用光致发光谱, TEM和EDS对微晶玻璃进行了表征分析, 并研究了热处理对上转换发光的影响。结果表明: 玻璃转变温度和析晶起始温度分别为799℃和880℃. 在980 nm激光激发下, 样品发射出中心位于497, 523, 545, 603和657 nm处的五条发光带。热处理后样品上转换发光强度提高, 经过880℃保温50 min热处理的微晶玻璃显示了最强的上转换发光, 在545 nm处的发光强度是前驱体玻璃的11倍, 这是由于在微晶玻璃基质中存在致密柱状晶和Nd³⁺离子在晶体中富集造成的。